SE378017B - - Google Patents

Info

Publication number
SE378017B
SE378017B SE7104503A SE450371A SE378017B SE 378017 B SE378017 B SE 378017B SE 7104503 A SE7104503 A SE 7104503A SE 450371 A SE450371 A SE 450371A SE 378017 B SE378017 B SE 378017B
Authority
SE
Sweden
Application number
SE7104503A
Inventor
C Malen
M Laubie
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of SE378017B publication Critical patent/SE378017B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/32Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof from compositions containing microballoons, e.g. syntactic foams

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
SE7104503A 1970-04-06 1971-04-06 SE378017B (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1611870 1970-04-06

Publications (1)

Publication Number Publication Date
SE378017B true SE378017B (cg-RX-API-DMAC7.html) 1975-08-11

Family

ID=10071505

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7104503A SE378017B (cg-RX-API-DMAC7.html) 1970-04-06 1971-04-06

Country Status (14)

Country Link
US (1) US3960891A (cg-RX-API-DMAC7.html)
JP (1) JPS4817274B1 (cg-RX-API-DMAC7.html)
AT (1) AT304549B (cg-RX-API-DMAC7.html)
BE (1) BE765313A (cg-RX-API-DMAC7.html)
CA (1) CA919683A (cg-RX-API-DMAC7.html)
CH (1) CH536849A (cg-RX-API-DMAC7.html)
DK (1) DK124547B (cg-RX-API-DMAC7.html)
FR (1) FR2092004B1 (cg-RX-API-DMAC7.html)
GB (1) GB1308191A (cg-RX-API-DMAC7.html)
IE (1) IE35034B1 (cg-RX-API-DMAC7.html)
NL (1) NL145858B (cg-RX-API-DMAC7.html)
SE (1) SE378017B (cg-RX-API-DMAC7.html)
SU (1) SU386517A3 (cg-RX-API-DMAC7.html)
ZA (1) ZA712169B (cg-RX-API-DMAC7.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52128486U (cg-RX-API-DMAC7.html) * 1976-03-25 1977-09-30
GB1561153A (en) * 1976-08-23 1980-02-13 Science Union & Cie Process for the preparation of thiochroman derivatives
JPS5366475U (cg-RX-API-DMAC7.html) * 1976-11-05 1978-06-03
US4410548A (en) * 1980-07-09 1983-10-18 Reckitt & Colman Products Limited Propanolamine derivatives
FR2498930A1 (fr) * 1981-01-30 1982-08-06 Science Union & Cie Nouvelles compositions pharmaceutiques a proprietes hemobiologiques contenant du 8- (3-(terbutylamino) 2-hydroxy propoxy) thiachromanne
FR2529785A1 (fr) * 1982-07-09 1984-01-13 Adir Composition pharmaceutique a base d'indapamide et de 8-(3-tertbutylamino 2-hydroxypropoxy)-thiachromanne
FR2530954B1 (fr) * 1982-07-29 1985-09-13 Adir Composition pharmaceutique a base de 8-(3-tertbutylamino, 2-hydroxy-propoxy)-thiachromanne
US4452810A (en) * 1983-09-12 1984-06-05 Stauffer Chemical Company Insect repellent: N,N-diethyl-2-(4-thiochromanyloxy)-propionamide
FR2588260B1 (fr) * 1985-10-04 1987-11-20 Adir Nouveau derive du thiochromanne, son procede de preparation et les compositions pharmaceutiques qui le contiennent
JPS6341451A (ja) * 1986-08-06 1988-02-22 Nippon Kayaku Co Ltd エ−テル誘導体およびそれを有効成分とする殺ダニ、殺虫組成物
US5140039A (en) * 1988-01-15 1992-08-18 Abbott Laboratories Aminomethyl-thiochroman compounds
FR2691149B1 (fr) * 1992-05-18 1994-07-08 Adir Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
EP0714663A3 (en) 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
WO1997006792A1 (en) * 1995-08-16 1997-02-27 Eli Lilly And Company Potentiation of serotonin response
US6974838B2 (en) * 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6331571B1 (en) 1998-08-24 2001-12-18 Sepracor, Inc. Methods of treating and preventing attention deficit disorders
US6339106B1 (en) 1999-08-11 2002-01-15 Sepracor, Inc. Methods and compositions for the treatment and prevention of sexual dysfunction
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
WO2002083631A1 (en) 2001-04-13 2002-10-24 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives
US7034059B2 (en) * 2001-07-02 2006-04-25 Sepracor Inc. Methods of using norfluoxetine
US20030087963A1 (en) 2001-09-13 2003-05-08 Senanayake Chris H. Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites
OA12905A (en) 2002-08-19 2006-10-13 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
MX2015014666A (es) 2013-04-17 2016-03-01 Pfizer Derivados de n-piperidin-3-ilbenzamida para tratar enfermedades cardiovasculares.
EP2959904A1 (en) 2014-06-27 2015-12-30 Institut De Recerca Contra La Leucemia Josep Carreras Methods for treating, diagnosing and prognosing a haematological malignancy
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
US11248001B2 (en) 2019-01-18 2022-02-15 Astrazeneca Ab PCSK9 inhibitors and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1129072A (en) * 1914-01-24 1915-02-23 Charles A Conn Pump-valve.
GB1058822A (en) * 1963-07-30 1967-02-15 Ici Ltd 3-amino-2-hydroxypropoxy heterocyclic derivatives
GB1047927A (en) * 1964-03-09 1966-11-09 Ici Ltd Alkanolamine derivatives
US3398161A (en) * 1965-06-30 1968-08-20 Ici Ltd Benzo (b) thiophen derivatives which have beta-adrenergic blocking activity
GB1261111A (en) * 1969-04-25 1972-01-19 Science Union & Cie New benzothiopyran derivatives and process for preparing them

Also Published As

Publication number Publication date
NL7104410A (cg-RX-API-DMAC7.html) 1971-10-08
DE2115201A1 (de) 1971-10-21
FR2092004B1 (cg-RX-API-DMAC7.html) 1975-11-28
FR2092004A1 (cg-RX-API-DMAC7.html) 1972-01-21
ZA712169B (en) 1972-01-26
SU386517A3 (cg-RX-API-DMAC7.html) 1973-06-14
IE35034L (en) 1971-10-06
GB1308191A (en) 1973-02-21
DE2115201B2 (de) 1976-02-19
JPS4817274B1 (cg-RX-API-DMAC7.html) 1973-05-28
NL145858B (nl) 1975-05-15
CA919683A (en) 1973-01-23
DK124547B (da) 1972-10-30
AT304549B (de) 1973-01-10
US3960891A (en) 1976-06-01
CH536849A (fr) 1973-05-15
BE765313A (fr) 1971-10-05
IE35034B1 (en) 1975-10-29

Similar Documents

Publication Publication Date Title
SU386517A3 (cg-RX-API-DMAC7.html)
AU2044470A (cg-RX-API-DMAC7.html)
AU1146470A (cg-RX-API-DMAC7.html)
AU2017870A (cg-RX-API-DMAC7.html)
AU1833270A (cg-RX-API-DMAC7.html)
AU1326870A (cg-RX-API-DMAC7.html)
AU2085370A (cg-RX-API-DMAC7.html)
AU2130570A (cg-RX-API-DMAC7.html)
AR195465A1 (cg-RX-API-DMAC7.html)
AU1247570A (cg-RX-API-DMAC7.html)
AU1086670A (cg-RX-API-DMAC7.html)
AU1235770A (cg-RX-API-DMAC7.html)
AU1789870A (cg-RX-API-DMAC7.html)
AU1832970A (cg-RX-API-DMAC7.html)
AU2119370A (cg-RX-API-DMAC7.html)
AU1841070A (cg-RX-API-DMAC7.html)
AU1872870A (cg-RX-API-DMAC7.html)
AU1879170A (cg-RX-API-DMAC7.html)
AU2144270A (cg-RX-API-DMAC7.html)
AU2131570A (cg-RX-API-DMAC7.html)
AU1189670A (cg-RX-API-DMAC7.html)
AU1277070A (cg-RX-API-DMAC7.html)
AU2130770A (cg-RX-API-DMAC7.html)
AU1881070A (cg-RX-API-DMAC7.html)
AU1918570A (cg-RX-API-DMAC7.html)